Rosetta Genomics Ltd. (NASDAQ:ROSG) the shining star, Paramount Gold & Silver Corp. (NYSEMKT:PZG)

Posted by Samantha Donahue May 20, 2013 0 Comment 1362 views


Miami, FL 05/20/2013 (GDPInsider) – Rosetta Genomics Ltd. (NASDAQ:ROSG) is up by whopping 13.41% representing a rise of $0.45 from its Friday’s close of $3.40 and is now trading close to $3.86, with about 0.828 million shares traded during the day. At the current levels the stock is almost 83.37% off its 52-week high of $23.43 and 26.08% above its 52-week low of $2.09. The relative strength index of the stock calculated over a period of 14 days is currently at 59.84 which reflect that the stock is neither trading in neither an oversold zone nor overbought zone. The stock is trading below its short and long moving average of 50 days and 200 days respectively, a sign of pessimism. The stock is 0.27% above its 50 days SMA and 17.35% below its 200 days SMA. It is trading above its short term 20 days SMA by about 15.88%.

The company announced about a credentialing agreement with Prime Health Services for including Rosetta Genomics’ miRview mets2 test in Prime Health’s covered products and services. The stock gained 11.8% in the premarket trading session.

How Should Investors Trade ROSG Now? Get the latest trends and data here.

Paramount Gold & Silver Corp. (NYSEMKT:PZG) is up by 2.76% representing a upside of $0.03 from its Friday’s close of $1.27 and is now trading close to $1.30, with about 0.663 million shares traded during the day. At the current levels the stock is almost 56.38% off its 52-week high of $2.82 and 11.81% off its 52-week low of $2.37. The relative strength index of the stock calculated over a period of 14 days is currently at 25.88 which reflect that the stock is trading in an oversold zone, thus we can expect the stock to bounce back after getting a support at some key levels. The stock is trading below its short and long moving average of 50 days and 200 days respectively, a sign of pessimism. The stock is 31.38% below its 50 days SMA and 44.62% below its 200 days SMA. It is also trading below its short term 20 days SMA by about 16.43%.

Is PZG a solid investment at these levels? Get valuable updates and exclusive insights here.

Disclosure:

WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.


About Samantha Donahue

Samantha Donahue is a digital fellow with GDP insider. Samantha earned a Bachelor's degree in Government from Cornell University and later his Master's degree in Journalism from Columbia University. She has also received numerous awards from the Associated Press, Society of Professional Journalists, and other media organizations for many of her exclusive stories. Samantha thrives reporting on breaking news and as a general assignments news reporter.

View all post by Samantha Donahue Visit author's website

Write Your Comment